High-dose vitamin D added to chemotherapy failed to provide a benefit in patients with metastatic colorectal cancer in the ...

Solaris, Europe’s embedded finance platform has taken the difficult decision to discontinue major parts of its Electronic ...

Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to report assay results from its ongoing 60,000m 2024 ...

Solaris Energy Infrastructure, Inc. (NYSE:SEI) (f/k/a Solaris Oilfield Infrastructure, Inc. (NYSE:SOI)) ("Solaris" or the ...

Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) ("Solaris" or the "Company") is pleased to report assay results from its ...

Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to provide an update on recent results ...

Learn more about Solaris Energy Infrastructure Inc's (SEI) stock grades for Value, Momentum, Growth and Estimate Revisions ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 18.25% ...

At Solaris, we are deeply passionate about the alternative protein sector and its transformative potential for sustainability ...

In recent days, eight Urbino 18 hydrogen buses from Solaris Bus & Coach recently joined the fleet of public transport ...

QUITO, Ecuador, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to report assay results from its ongoing 60,000m ...

Discover the SOLARIS trial findings on high-dose Vitamin D3 for metastatic colorectal cancer. Learn about its impact on ...